Boothbay Fund Management »

Blueprint Medicines shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $34M 387k 88.51
2024-12-31 $17M 190k 87.22
2024-09-30 $2.3M 25k 92.50
2022-06-30 $394k 7.8k 50.51
2022-03-31 $498k 7.8k 63.85
2021-09-30 $267k 2.6k 102.85
2021-06-30 $262k 3.0k 88.07
2021-03-31 $233k 2.4k 97.16
2020-06-30 $1.9M 24k 78.00
2019-06-30 $462k 4.9k 94.29
2019-03-31 $489k 6.1k 80.11
2018-12-31 $399k 7.4k 53.91
2018-09-30 $455k 5.8k 78.14
2017-03-31 $1.8M 45k 40.00